Clinical Trial Details


Research Study Summary

An observational, multi-center study to evaluate the safety of deferasirox in the treatment of pediatric patients with non-transfusion-dependent iron overload.


The purpose of this observational study is to provide further assessment of the safety of deferasirox in NTDT pediatric patients with documented iron overload as defined in a local product label.

To Learn more

CW ID: 210600
Date Last Changed: September 30, 2015

Clinical Trial Snapshot

Both Male and Female
10 to 18 Years
Overall Status
Lead Sponsor
Facility Type


Inclusion criteria:

Patients eligible for inclusion in this study must meet all of the following criteria:

  • Male or female aged ≥ 10 but <18 years old with non-transfusion-dependent thalassemia syndromes inclusive of beta-thalassemia intermedia, HbE beta-thalassemia or alpha thalassemia intermedia (HbH disease) and chronic iron overload
  • AND
  • Patients currently treated for a maximum of 12 months or patients planned to be treated with deferasirox
  • AND
  • Written informed consent obtained prior to any screening procedures. The consent form will be signed by the patient’s legal guardian

Exclusion Criteria:

  • Patients treated with deferasirox in an interventional clinical study

More Info

Protocol Number: CICL670E2422


Emma Gonzalez
University of South Florida- South Tampa Center for Advanced Healthcare
2 Tampa General Circle
Tampa, FL 33606
Phone: 813-259-8813

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.